Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
PEC Innovation
|
January 16, 2025
A lifestyle educational course as an adjunct to biologic administration in patients with severe asthma: A feasibility study
Joseph W Lanario, Drew Davies, Lucy Cartwright, et al.
Respiratory Medicine
|
February 15, 2020
Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma
Joseph W Lanario, Michael E Hyland, Yinghui Wei, et al.
The European Respiratory Journal
|
December 30, 2022
Moving towards patient-centred outcomes: the Severe Asthma Questionnaire
Drew Davies, Michael E Hyland, Joseph W Lanario, et al.
Health and Quality of Life Outcomes
|
January 29, 2018
How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
Michael E Hyland, Joseph W Lanario, Jill Pooler, et al.
Immunity, Inflammation and Disease
|
August 24, 2019
Evidence for similarity in symptoms and mechanism: The extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia
Michael E Hyland, Joseph W Lanario, Yinghui Wei, et al.
BMC Pulmonary Medicine
|
November 27, 2022
"Life-changing": the experience of super-responders to biologics in severe asthma
Joseph W Lanario, Lucy Cartwright, Rupert C Jones, et al.
BMC Pulmonary Medicine
|
November 15, 2021
Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma
Giulio de Felice, Michael E Hyland, Joseph W Lanario, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 16, 2021
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
John W Upham, Chantal Le Lievre, David J Jackson, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 11, 2022
Reply to "'Nothing about us without us' - What matters to patients with severe asthma?"
John W Upham, Chantal Le Lievre, David J Jackson, et al.
BMJ Open
|
August 11, 2016
Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)
Robert M Niven, Dinesh Saralaya, Rekha Chaudhuri, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
PEC Innovation
|
January 16, 2025
A lifestyle educational course as an adjunct to biologic administration in patients with severe asthma: A feasibility study
Joseph W Lanario, Drew Davies, Lucy Cartwright, et al.
Respiratory Medicine
|
February 15, 2020
Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma
Joseph W Lanario, Michael E Hyland, Yinghui Wei, et al.
The European Respiratory Journal
|
December 30, 2022
Moving towards patient-centred outcomes: the Severe Asthma Questionnaire
Drew Davies, Michael E Hyland, Joseph W Lanario, et al.
Health and Quality of Life Outcomes
|
January 29, 2018
How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
Michael E Hyland, Joseph W Lanario, Jill Pooler, et al.
Immunity, Inflammation and Disease
|
August 24, 2019
Evidence for similarity in symptoms and mechanism: The extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia
Michael E Hyland, Joseph W Lanario, Yinghui Wei, et al.
BMC Pulmonary Medicine
|
November 27, 2022
"Life-changing": the experience of super-responders to biologics in severe asthma
Joseph W Lanario, Lucy Cartwright, Rupert C Jones, et al.
BMC Pulmonary Medicine
|
November 15, 2021
Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma
Giulio de Felice, Michael E Hyland, Joseph W Lanario, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
July 16, 2021
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
John W Upham, Chantal Le Lievre, David J Jackson, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 11, 2022
Reply to "'Nothing about us without us' - What matters to patients with severe asthma?"
John W Upham, Chantal Le Lievre, David J Jackson, et al.
BMJ Open
|
August 11, 2016
Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)
Robert M Niven, Dinesh Saralaya, Rekha Chaudhuri, et al.
Page
of 4